Trial Profile
Phase I Study of GDC-0941 alone in Patients with Solid Tumors or GDC-0941 in Combination with Carboplatin / Paclitaxel + Bevacizumab in Patients with Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Pictrelisib (Primary) ; Bevacizumab; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 27 Aug 2016 Results published in the Investigational New Drugs
- 19 Jan 2016 New trial record